YOLFTbeta
30

Contec Medical Systems Co Ltd

300869 · SHE · Healthcare / Medical Devices

9.47CNY-0.33 (-3.37%)

Price History

Full chart

Market Stats

Previous Close9.80
Open9.77
Day Range9.44 – 9.80
52-Week Range9.98 – 18.10
Volume4.93M
Market Cap4.56B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.22
Dividend Yield0.00%
Beta0.12
50-Day Avg11.17
200-Day Avg12.85

About

Contec Medical Systems Co.,Ltd engages in the research and development, production, and sale of medical diagnosis, monitoring equipment, and digital healthcare services in China and internationally. The company offers electronic sphygmomanometers, ambulatory blood pressure monitors, pulse oximeters, patient monitors, stethoscopes, simulators, multi-parameter vital signs monitors, central monitoring systems, electrocardiograph products, endoscopes, pocket fetal dopplers, fetal monitors, ultrasound diagnostic systems, analyzers, infusion pumps, digital brain electric activity mapping and EMG/EP systems, nebulizers, spirometers, blood glucose meters, uric acid meters, oxygen concentrators, capnographs, and airway pressure devices. It also provides infusion and syringe pumps, massagers, sleep and snoring aids, and thermometers; and telemedicine and veterinary products, dispensing appliances, electronic colposcope, and accessories. In addition, the company engages in the import and export, trade, related consulting, and customer service of medical equipment; marketing activities; technical development, production, and sale of molds; and production and sale of bio-based materials and dental products. It sells its products through distributors. Contec Medical Systems Co.,Ltd was founded in 1996 and is headquartered in Qinhuangdao, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Yang Zhishan
  • Employees1.71K
  • HeadquartersNo.112 Qinhuang West Street, Qinhuangdao, China, 066004, China
  • Websitehttps://www.contecmed.com

Leadership

  • Mr. Yang ZhishanGM & Director · b. 1963
  • Ms. Min ZhengDeputy GM, Financial Director & Board Secretary · b. 1975
  • Mr. Guozhi KouDeputy GM & Non-Independent Director · b. 1977
  • Mr. Chunyuan FuDeputy General Manager · b. 1968
  • Mr. Zhenhong LiuDeputy General Manager · b. 1976
  • Mr. Yunlong XuDeputy General Manager · b. 1978
  • Di WangAccounting Supervisor

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue213.59M252.13M284.43M442.09M397.80M362.66M387.25M1.40B908.71M712.11M746.90M479.81M468.00M
Growth (%)-+18.05%+12.81%+55.43%-10.02%-8.84%+6.78%+261.84%-35.15%-21.63%+4.89%-35.76%-2.46%
Cost of Revenue89.69M116.57M137.56M233.55M204.98M192.69M207.50M591.54M476.88M382.12M359.82M356.53M243.14M
Gross Profit123.89M135.57M146.87M208.55M192.83M169.96M179.74M809.69M431.83M330.00M387.08M123.27M224.86M
Gross Margin58.01%53.77%51.64%47.17%48.47%46.87%46.42%57.78%47.52%46.34%51.83%25.69%48.05%
Operating Expense73.54M86.11M88.23M111.79M108.24M100.49M98.15M95.05M26.08M110.72M200.35M190.82M238.85M
Operating Income50.35M49.45M58.64M96.76M84.59M69.47M81.59M714.64M405.75M219.28M186.73M-67.55M-13.98M
Operating Margin23.57%19.61%20.62%21.89%21.26%19.16%21.07%51.00%44.65%30.79%25.00%-14.08%-2.99%
EBITDA65.08M73.21M84.56M134.74M103.54M84.69M87.01M734.54M429.45M259.04M259.04M-11.02M38.07M
EBITDA Margin30.47%29.04%29.73%30.48%26.03%23.35%22.47%52.42%47.26%36.38%34.68%-2.30%8.13%
Net Income53.79M54.46M61.53M103.49M77.06M62.03M73.78M613.40M352.35M196.20M165.77M-77.90M-24.42M
Net Income Margin25.18%21.60%21.63%23.41%19.37%17.10%19.05%43.78%38.78%27.55%22.19%-16.24%-5.22%
R&D19.28M29.84M30.12M38.31M35.01M34.39M40.57M48.74M66.06M93.25M110.60M105.16M91.66M
R&D as % of Total Revenue9.03%11.84%10.59%8.67%8.80%9.48%10.48%3.48%7.27%13.10%14.81%21.92%19.59%
Interest Expense3.74M932.11K816.30K402.86K546.40K392.90K588.80K3.90M3.81M20.68M47.38M36.88M37.43M
Interest Expense % of Total Revenue1.75%0.37%0.29%0.09%0.14%0.11%0.15%0.28%0.42%2.90%6.34%7.69%8.00%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets273.03M304.08M423.14M494.97M554.10M575.37M679.20M2.10B2.79B3.73B3.21B2.73B2.77B
Total Liabilities90.02M75.08M129.84M123.95M107.60M66.14M95.98M529.00M968.99M1.80B1.17B868.10M1.04B
Total Equity183.01M229.00M293.29M371.02M446.51M509.23M583.23M1.57B1.82B1.93B2.04B1.86B1.73B
Cash20.65M26.03M61.00M166.67M225.59M241.84M184.30M814.07M623.98M1.39B470.53M684.31M982.72M
Total Debt--13.82M844.60K576.50K-18.88M267.94M804.33M1.58B1.05B785.36M-
Net Debt-20.65M-26.03M-47.18M-165.82M-225.02M-241.84M-165.43M-546.13M180.35M183.34M574.76M101.05M-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow74.41M36.45M35.23M130.64M117.61M29.81M50.22M597.73M4.65M103.66M181.01M62.34M22.29M
Investing Cash Flow-36.62M-25.17M-23.05M-13.46M-102.93M-41.83M-25.89M-314.85M-51.09M-113.82M-830.62M-105.68M-
Financing Cash Flow-49.52M-7.03M3.63M-9.20M-13.35M-7.84M-2.98M378.60M-165.62M781.34M-383.44M256.26M-
Capital Expenditure37.67M15.17M14.00M13.67M3.06M11.86M7.43M88.67M106.31M81.45M30.74M54.46M49.48M
Free Cash Flow36.74M21.28M21.23M116.98M114.55M17.94M42.79M509.06M-101.66M22.21M150.28M7.88M-27.19M
Dividends Paid10.75M7.03M26.04M122.77M1.86M1.86M1.86M1.86M102.31M120.54M68.70M127.72M112.11M
FCF to OCF49.38%58.38%60.27%89.54%97.40%60.19%85.20%85.17%-2187.52%21.43%83.02%12.64%-122.00%
Dividend Paid to FCF29.27%33.03%122.65%104.95%1.62%10.36%4.34%0.36%-100.63%542.72%45.71%1620.39%-412.31%

Earnings

Report DateSep 30, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Dec 31, 2023May 16, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------
EPS Actual0.380.240.290.220.210.160.180.100.150.050.420.03-0.070.010.010.00-0.220.040.00-0.02-0.08-0.02-0.10
Surprise-----------------------
Timing-------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap4.56B
Enterprise Value3.62B
Trailing P/E0.00
Forward P/E0.00
Price / Sales9.57
Price / Book2.76
EPS-0.22
Book Value4.19
Revenue (TTM)476.33M
Gross Profit (TTM)155.96M
EBITDA-67.73M
Profit Margin-19.03%
Operating Margin-28.70%
Return on Equity-5.24%
Return on Assets-2.18%
Shares Outstanding401.80M
Shares Float198.16M
Beta0.12
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.25May 30, 2025
20241×
0.30May 29, 2024
20231×
0.13Jun 20, 2023
20221×
0.30May 27, 2022
20211×
0.25May 18, 2021